
### [NCIT:C4665](http://purl.obolibrary.org/obo/NCIT_C4665)
**Label:** Plasma Cell Neoplasm

**Subclasses:** [NCIT:C4734](http://purl.obolibrary.org/obo/NCIT_C4734) (Non-Secretory Plasma Cell Myeloma), [NCIT:C7813](http://purl.obolibrary.org/obo/NCIT_C7813) (Refractory Plasma Cell Neoplasm), [NCIT:C7765](http://purl.obolibrary.org/obo/NCIT_C7765) (Osteosclerotic Plasma Cell Myeloma), [NCIT:C7149](http://purl.obolibrary.org/obo/NCIT_C7149) (Smoldering Plasma Cell Myeloma), [NCIT:C7812](http://purl.obolibrary.org/obo/NCIT_C7812) (Solitary Osseous Plasmacytoma), [NCIT:C9349](http://purl.obolibrary.org/obo/NCIT_C9349) (Plasmacytoma), [NCIT:C6932](http://purl.obolibrary.org/obo/NCIT_C6932) (Solitary Plasmacytoma), [NCIT:C4002](http://purl.obolibrary.org/obo/NCIT_C4002) (Extraosseous Plasmacytoma), [NCIT:C7241](http://purl.obolibrary.org/obo/NCIT_C7241) (Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder), [NCIT:C3242](http://purl.obolibrary.org/obo/NCIT_C3242) (Plasma Cell Myeloma), [NCIT:C7240](http://purl.obolibrary.org/obo/NCIT_C7240) (Plasma Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7242](http://purl.obolibrary.org/obo/NCIT_C7242) (Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder), [NCIT:C118421](http://purl.obolibrary.org/obo/NCIT_C118421) (Anaplastic Plasmacytoma), [NCIT:C3180](http://purl.obolibrary.org/obo/NCIT_C3180) (Plasma Cell Leukemia), 

**Class expressions from DL-Learner:**

- Thing 53.10%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40261](http://purl.obolibrary.org/obo/NCIT_C40261) (Vaginal Adenoid Cystic Carcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40260](http://purl.obolibrary.org/obo/NCIT_C40260) (Vaginal Adenosquamous Carcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40259](http://purl.obolibrary.org/obo/NCIT_C40259) (Vaginal Villous Adenoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40258](http://purl.obolibrary.org/obo/NCIT_C40258) (Vaginal Tubulovillous Adenoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40257](http://purl.obolibrary.org/obo/NCIT_C40257) (Vaginal Tubular Adenoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40255](http://purl.obolibrary.org/obo/NCIT_C40255) (Vaginal Mullerian Papilloma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40252](http://purl.obolibrary.org/obo/NCIT_C40252) (Vaginal Mucinous Adenocarcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40251](http://purl.obolibrary.org/obo/NCIT_C40251) (Vaginal Endometrioid Adenocarcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40248](http://purl.obolibrary.org/obo/NCIT_C40248) (Vaginal Warty Carcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40245](http://purl.obolibrary.org/obo/NCIT_C40245) (Vaginal Basaloid Carcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40243](http://purl.obolibrary.org/obo/NCIT_C40243) (Vaginal Keratinizing Squamous Cell Carcinoma))) 38.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40239](http://purl.obolibrary.org/obo/NCIT_C40239) (Cervical Melanoma))) 38.69%


